Lamisil and Inderal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamisil (terbinafine hydrochloride) and Inderal (propranolol hydrochloride). Common drug interactions include neuropathy peripheral among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Lamisil and Inderal. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Inderal?

Inderal has active ingredients of propranolol hydrochloride. It is often used in migraine. eHealthMe is studying from 16,771 Inderal users. Check the latest studies of Inderal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 16, 2026

74 people who take Lamisil and Inderal together, and have interactions are studied.

Lamisil and Inderal drug interactions.

What are the common drug interactions of Lamisil and Inderal, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Oedema (fluid collection in tissue)
  3. Pruritus (severe itching of the skin)
  4. Pulmonary mass
  5. Rash erythematous (redness of the skin)
  6. Swelling
  7. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Visual acuity reduced (reduced clearness of vision)
  10. Visual disturbance

male:

  1. Pruritus (severe itching of the skin)
  2. Discomfort
  3. Skin discolouration (change of skin colour)
  4. Skin exfoliation (removal of the oldest dead skin cells)
  5. Skin lesion
  6. Skin plaque (red, scaly patches to appear on the skin)
  7. Transient acantholytic dermatosis (a skin condition that causes the appearance of small, red spots on chest and back)
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Arthropathy
  10. Suicidal ideation

What are the common drug interactions of Lamisil and Inderal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Visual disturbance
  2. Vomiting
  3. Abdominal pain
  4. Abdominal pain upper
  5. Affect lability (emotional incontinence)
  6. Alanine aminotransferase increased
  7. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  8. Aspartate aminotransferase increased
  9. Bacterial infection
  10. Blood albumin decreased

50-59:

  1. Body temperature decreased
  2. Discomfort
  3. Haemorrhage (bleeding)
  4. Pruritus (severe itching of the skin)
  5. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  6. Erythema (redness of the skin)
  7. Headache (pain in head)
  8. Injection site reaction
  9. Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin))
  10. Papule

60+:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Alopecia (absence of hair from areas of the body)
  3. Bedridden
  4. Carotid artery stenosis (narrowing of carotid artery)
  5. Cerebral infarction (less blood supply to brain resulting tissue damage)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  9. Dysphasia (language disorder marked by deficiency in the generation of speech)
  10. Dysstasia (difficulty in standing)

What are the existing conditions these people have? *

  1. Pain: 27 people, 36.49%
  2. Urticaria (rash of round, red welts on the skin that itch intensely): 10 people, 13.51%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 12.16%
  4. Nail Tinea (fungal infection of nail): 4 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and Inderal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lamisil and Inderal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Inderal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamisil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Inderal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride and propranolol hydrochloride (the active ingredients of Lamisil and Inderal, respectively), and Lamisil and Inderal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: